{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T19:54:41Z","timestamp":1793390081578,"version":"4.5.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000156","name":"Fonds de Recherche du Qu\u00e9bec - Sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007867","name":"Universit\u00e9 Laval","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007867","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajogmfm.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics &amp; Gynecology MFM"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.ajogmf.2023.101000","type":"journal-article","created":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T02:52:16Z","timestamp":1683168736000},"page":"101000","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"title":["Comparing aspirin 75 to 81 mg vs 150 to 162 mg for prevention of preterm preeclampsia: systematic review and meta-analysis"],"prefix":"10.1016","volume":"5","author":[{"given":"Louise","family":"Ghesquiere","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Guerby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isobel","family":"Marchant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Namrata","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjan","family":"Zare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Anne","family":"Foisy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Roberge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6936-4369","authenticated-orcid":false,"given":"Emmanuel","family":"Bujold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajogmf.2023.101000_bib0001","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1097\/AOG.0000000000003892","article-title":"Gestational hypertension and preeclampsia: ACOG Practice Bulletin Summary, Number 222","volume":"135","year":"2020","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2023.101000_bib0002","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0140-6736(20)32335-7","volume":"398","author":"Chappell","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ajogmf.2023.101000_bib0003","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1053\/j.semperi.2009.02.010","article-title":"The global impact of pre-eclampsia and eclampsia","volume":"33","author":"Duley","year":"2009","journal-title":"Semin Perinatol"},{"key":"10.1016\/j.ajogmf.2023.101000_bib0004","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/S0140-6736(10)60518-1","article-title":"Maternal mortality for 181 countries, 1980-2008: a systematic analysis of progress towards Millennium Development Goal 5","volume":"375","author":"Hogan","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ajogmf.2023.101000_bib0005","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/GCO.0b013e32835e0ef5","article-title":"Hypertensive disease of pregnancy and maternal mortality","volume":"25","author":"Lo","year":"2013","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2023.101000_bib0006","doi-asserted-by":"crossref","first-page":"e323","DOI":"10.1016\/S2214-109X(14)70227-X","article-title":"Global causes of maternal death: a WHO systematic analysis","volume":"2","author":"Say","year":"2014","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.ajogmf.2023.101000_bib0007","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0140-6736(10)60279-6","volume":"376","author":"Steegers","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ajogmf.2023.101000_bib0008","doi-asserted-by":"crossref","first-page":"k4109","DOI":"10.1136\/bmj.k4109","article-title":"Pre-eclampsia and risk of dementia later in life: nationwide cohort study","volume":"363","author":"Basit","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.ajogmf.2023.101000_bib0009","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.earlhumdev.2014.08.012","article-title":"prematurity and cardiovascular health in adult life","volume":"90","author":"Lewandowski","year":"2014","journal-title":"Early Hum Dev"},{"key":"10.1016\/j.ajogmf.2023.101000_bib0010","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.ahj.2008.06.042","article-title":"Cardiovascular sequelae of preeclampsia\/eclampsia: a systematic review and meta-analyses","volume":"156","author":"McDonald","year":"2008","journal-title":"Am Heart J"},{"key":"10.1016\/j.ajogmf.2023.101000_bib0011","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1097\/AOG.0000000000002364","article-title":"Long-term risk of a seizure disorder after eclampsia","volume":"130","author":"Nerenberg","year":"2017","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2023.101000_bib0012","doi-asserted-by":"crossref","first-page":"725","DOI":"10.14283\/jpad.2022.62","article-title":"Association of preeclampsia with incident dementia and Alzheimer's disease among women in the Framingham offspring study","volume":"9","author":"Wang","year":"2022","journal-title":"J Prev Alzheimers Dis"},{"key":"10.1016\/j.ajogmf.2023.101000_bib0013","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/uog.19112","article-title":"Screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks\u2019 gestation","volume":"52","author":"Tan","year":"2018","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2023.101000_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2020.07.020","article-title":"First trimester preeclampsia screening and prediction","volume":"226","author":"Chaemsaithong","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2023.101000_bib0015","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/AOG.0b013e3181e9322a","article-title":"Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis","volume":"116","author":"Bujold","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2023.101000_bib0016","first-page":"551","article-title":"Early administration of low-dose aspirin for the prevention of severe and mild preeclampsia: a systematic review and meta-analysis","volume":"29","author":"Roberge","year":"2012","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.ajogmf.2023.101000_bib0017","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000336662","article-title":"Early administration of low-dose aspirin for the prevention of preterm and term preeclampsia: a systematic review and meta-analysis","volume":"31","author":"Roberge","year":"2012","journal-title":"Fetal Diagn Ther"},{"key":"10.1016\/j.ajogmf.2023.101000_bib0018","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/S0140-6736(07)60712-0","article-title":"Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data","volume":"369","author":"Askie","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ajogmf.2023.101000_bib0019","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1001\/jama.2021.8551","article-title":"Aspirin use to prevent preeclampsia and related morbidity and mortality: updated evidence report and systematic review for the US Preventive Services Task Force","volume":"326","author":"Henderson","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.ajogmf.2023.101000_bib0020","doi-asserted-by":"crossref","first-page":"613","DOI":"10.7326\/L14-5020-5","article-title":"Low-dose aspirin for prevention of morbidity and mortality from preeclampsia","volume":"161","author":"Henderson","year":"2014","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ajogmf.2023.101000_bib0021","article-title":"Antiplatelet agents for preventing pre-eclampsia and its complications","volume":"2019","author":"Duley","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajogmf.2023.101000_bib0022","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/uog.18816","article-title":"ASPRE trial: performance of screening for preterm pre-eclampsia","volume":"50","author":"Rolnik","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2023.101000_bib0023","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1056\/NEJMoa1704559","article-title":"Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia","volume":"377","author":"Rolnik","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajogmf.2023.101000_bib0024","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0247782","article-title":"Dose of aspirin to prevent preterm preeclampsia in women with moderate or high-risk factors: a systematic review and meta-analysis","volume":"16","author":"Van Doorn","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.ajogmf.2023.101000_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2017.11.561","article-title":"Aspirin for the prevention of preterm and term preeclampsia: systematic review and metaanalysis","volume":"218","author":"Roberge","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2023.101000_bib0026","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1515\/jpm.2011.098","article-title":"Placental lesions associated with maternal underperfusion are more frequent in early-onset than in late-onset preeclampsia","volume":"39","author":"Ogge","year":"2011","journal-title":"J Perinat Med"},{"key":"10.1016\/j.ajogmf.2023.101000_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2019.02.034","article-title":"Aspirin delays the development of preeclampsia","volume":"220","author":"Wright","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2023.101000_bib0028","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1093\/eurheartj\/ehy340","article-title":"2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy","volume":"39","author":"Regitz-Zagrosek","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ajogmf.2023.101000_bib0029","doi-asserted-by":"crossref","first-page":"l5119","DOI":"10.1136\/bmj.l5119","article-title":"Diagnosis and management of hypertension in pregnancy: summary of updated NICE guidance","volume":"366","author":"Webster","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.ajogmf.2023.101000_bib0030","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1055\/s-0036-1572495","article-title":"Low-dose aspirin in early gestation for prevention of preeclampsia and small-for-gestational-age neonates: meta-analysis of large randomized trials","volume":"33","author":"Roberge","year":"2016","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.ajogmf.2023.101000_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2016.09.076","article-title":"The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis","volume":"216","author":"Roberge","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2023.101000_bib0032","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1097\/AOG.0000000000002708","article-title":"ACOG Committee Opinion No. 743: low-dose aspirin use during pregnancy","volume":"132","year":"2018","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2023.101000_bib0033","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1001\/jama.2021.14781","article-title":"Aspirin use to prevent preeclampsia and related morbidity and mortality: US Preventive Services Task Force recommendation statement","volume":"326","author":"Preventive Services Task Force","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.ajogmf.2023.101000_bib0034","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.jogc.2022.03.002","article-title":"Guideline No. 426: hypertensive disorders of pregnancy: diagnosis, prediction, prevention, and management","volume":"44","author":"Magee","year":"2022","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.ajogmf.2023.101000_bib0035","doi-asserted-by":"crossref","unstructured":"Mounier-Vehier C, Amar J, Boivin JM, et al. Hypertension art\u00e9rielle et grossesse. Consensus d'experts de la Soci\u00e9t\u00e9 fran\u00e7aise d'hypertension art\u00e9rielle, filiale de la Soci\u00e9t\u00e9 fran\u00e7aise de cardiologie. Presse M\u00e9dicale. 2016;45(7, Part 1):682\u2013699. doi:10.1016\/j.lpm.2016.05.012","DOI":"10.1016\/j.lpm.2016.05.012"},{"key":"10.1016\/j.ajogmf.2023.101000_bib0036","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.ajogmf.2023.101000_bib0037","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000100","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"6","author":"Liberati","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.ajogmf.2023.101000_bib0038","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ejogrb.2020.03.038","article-title":"Effects of low-dose aspirin on the prevention of preeclampsia and pregnancy outcomes: a randomized controlled trial from Shanghai, China","volume":"248","author":"Gu","year":"2020","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ajogmf.2023.101000_bib0039","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3892\/etm.2016.3924","article-title":"Effect of a small dose of aspirin on quantitative test of 24-h urinary protein in patients with hypertension in pregnancy","volume":"13","author":"Liu","year":"2017","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.ajogmf.2023.101000_bib0040","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0090-6980(96)00024-X","article-title":"Dose-related effects of low dose aspirin on hemostasis parameters and prostacyclin\/thromboxane ratios in late pregnancy","volume":"51","author":"Martin","year":"1996","journal-title":"Prostaglandins"},{"key":"10.1016\/j.ajogmf.2023.101000_bib0041","doi-asserted-by":"crossref","first-page":"S509","DOI":"10.1016\/j.ajog.2021.11.839","article-title":"Efficacy and safety of aspirin 162 mg prophylaxis for preeclampsia prevention in high risk women","volume":"226","author":"Ayyash","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2023.101000_bib0042","unstructured":"Anastasiu DM. THE 13 th CONFERENCE OF THE ROMANIAN-GERMAN SOCIETY OF OBSTETRICS AND GYNECOLOGY. EBOOK Proceedings 2017."},{"key":"10.1016\/j.ajogmf.2023.101000_bib0043","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/j.jogc.2020.05.013","article-title":"A pilot randomized trial comparing the effects of 80 versus 160 mg of aspirin on midtrimester uterine artery pulsatility index in women with a history of preeclampsia","volume":"42","author":"Tapp","year":"2020","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.ajogmf.2023.101000_bib0044","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s13224-019-01277-5","article-title":"Pilot interventional study comparing fetomaternal outcomes of 150 mg versus 75 mg aspirin starting between 11 and 14 weeks of pregnancy in patients with high risk of preeclampsia: a randomized control trial","volume":"70","author":"Kumar","year":"2020","journal-title":"J Obstet Gynaecol India"},{"key":"10.1016\/j.ajogmf.2023.101000_bib0045","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1515\/jpm-2021-0668","article-title":"The effect of 150 and 80 mg doses of aspirin on preventing preterm birth in high-risk pregnant women","volume":"50","author":"Kasraeian","year":"2022","journal-title":"J Perinat Med"},{"key":"10.1016\/j.ajogmf.2023.101000_bib0046","article-title":"Effect of aspirin dose on preeclampsia prevention and fetal-maternal complications: a randomized clinical trial","volume":"11","author":"Chamani","year":"2022","journal-title":"Jundishapur J Chronic Dis Care"},{"key":"10.1016\/j.ajogmf.2023.101000_bib0047","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.jogc.2017.07.025","article-title":"Maternal characteristics for the prediction of preeclampsia in nulliparous women: the great obstetrical syndromes (GOS) study","volume":"40","author":"Boutin","year":"2018","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.ajogmf.2023.101000_bib0048","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1136\/bmj.38380.674340.E0","article-title":"Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies","volume":"330","author":"Duckitt","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.ajogmf.2023.101000_bib0049","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.ajog.2017.07.038","article-title":"Aspirin for evidence-based preeclampsia prevention trial: effect of aspirin in prevention of preterm preeclampsia in subgroups of women according to their characteristics and medical and obstetrical history","volume":"217","author":"Poon","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2023.101000_bib0050","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/S0140-6736(79)92334-1","article-title":"Differential inhibition of prostacyclin production and platelet aggregation by aspirin","volume":"2","author":"Masotti","year":"1979","journal-title":"Lancet"},{"key":"10.1016\/j.ajogmf.2023.101000_bib0051","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/bcpt.13308","article-title":"Aspirin for the prevention and treatment of pre-eclampsia: a matter of COX-1 and\/or COX-2 inhibition?","volume":"127","author":"Mirabito Colafella","year":"2020","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.ajogmf.2023.101000_bib0052","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ajog.2019.04.027","article-title":"A pharmacokinetic assessment of optimal dosing, preparation, and chronotherapy of aspirin in pregnancy","volume":"221","author":"Shanmugalingam","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2023.101000_bib0053","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0002-9378(99)70163-8","article-title":"Effect of aspirin in pregnant women is dependent on increase in bleeding time","volume":"180","author":"Dumont","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2023.101000_bib0054","first-page":"334","article-title":"Aspirin resistance may be associated with adverse pregnancy outcomes","volume":"32","author":"W\u00f3jtowicz","year":"2011","journal-title":"Neuro Endocrinol Lett"},{"key":"10.1016\/j.ajogmf.2023.101000_bib0055","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/S1701-2163(16)34346-8","article-title":"Low-dose ASA response using the PFA-100 in women with high-risk pregnancy","volume":"31","author":"Caron","year":"2009","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.ajogmf.2023.101000_bib0056","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ejogrb.2011.02.026","article-title":"Is testing for aspirin response worthwhile in high-risk pregnancy?","volume":"157","author":"Rey","year":"2011","journal-title":"Eur J Obstet Gynecol Reprod Biol"}],"container-title":["American Journal of Obstetrics &amp; Gynecology MFM"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589933323001428?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589933323001428?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T23:52:12Z","timestamp":1762905132000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589933323001428"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":56,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S2589933323001428"],"URL":"https:\/\/doi.org\/10.1016\/j.ajogmf.2023.101000","relation":{},"ISSN":["2589-9333"],"issn-type":[{"value":"2589-9333","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparing aspirin 75 to 81 mg vs 150 to 162 mg for prevention of preterm preeclampsia: systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics & Gynecology MFM","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajogmf.2023.101000","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101000"}}